Viewing nowLykanyuro Extended Release Tablets 300 mg (Pregabalin)
Pregabalin 188.5mg
Tablet · Prescription medication
Dae Won Pharmaceutical Co., Ltd.

MFDS item code 201900142 · Approved 2019.01.11 · Insurance code 671806820
Treatment of peripheral neuropathic pain in adults
This medication is used in adults to relieve pain caused by peripheral neuropathy. Peripheral neuropathy is a pain condition caused by nerve damage, which can cause significant discomfort in daily life. This treatment effectively manages neuropathic pain and can improve the patient's quality of life. Therefore, it is used for the treatment of peripheral neuropathic pain in adults.
This medicine should be administered once daily after the evening meal. It should be swallowed whole and should not be split, crushed, or chewed. A starting dose of 150 mg per day may be administered. Based on each patient's response and tolerability, the dose may be increased at weekly intervals to a maximum of 600 mg per day. Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually, with intervals of at least 1 week. The safety and efficacy of this medicine have not been established in patients with renal impairment. The safety and efficacy of this medicine have not been established in patients with hepatic impairment. The safety and efficacy of this medicine have not been established in older adults aged 65 years or older.
Pediatric and adolescent patients under 19 years of age: The safety and efficacy of this medicine have not been established.
This medication may increase the risk of suicidal thoughts or behaviors; therefore, if there is any change in mood or behavior while taking this medication, immediate consultation with medical personnel is required. Patients with hypersensitivity to this medication should not take it. Diabetic patients should be careful as dosage adjustments for blood glucose control medications may be necessary due to weight gain. If symptoms of angioedema occur, such as swelling of the face or around the mouth, this medication should be stopped immediately, and medical advice should be sought. Elderly patients may experience symptoms such as dizziness, drowsiness, or loss of consciousness, hence caution is especially necessary during the initial period of use. Vision blurriness or changes in eyesight may occur, and these symptoms can improve upon discontinuation of the medication. When discontinuing this medication, withdrawal symptoms such as insomnia, headache, and anxiety may appear, so consultation with medical personnel is necessary. Patients with a history of substance abuse may be at higher risk of abuse of this medication, so careful use is required. Patients with impaired kidney function may require dosage adjustments. Patients with severe heart disease should exercise caution when taking this medication. The risk of central nervous system depression may increase when taken with opioid analgesics, thus caution is advised. Patients with weak respiratory function or the elderly may be at risk of severe respiratory depression and may require adjusted dosing. In early pregnancy, there is a risk of fetal malformations; therefore, women who are pregnant or planning to become pregnant should consult a physician before taking this medication and should use effective contraception. Dizziness and drowsiness may frequently occur while taking this medication, so caution is advised when driving or operating dangerous machinery. Severe skin reactions may rarely occur; thus, if any skin abnormalities appear, take this medication immediately. Stop taking it and inform medical personnel. In case of overdose, symptoms such as drowsiness, confusion, and seizures may occur, requiring immediate emergency treatment. Keep out of reach of children and do not transfer to another container for safety. This medication is primarily excreted through the kidneys, and interactions with other drugs are minimal, but caution should be exercised when taken with alcohol or central nervous system depressants. During breastfeeding, this medication may be transmitted through breast milk; consultation with medical personnel regarding whether to continue breastfeeding is required.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is recommended to maintain the storage temperature between 1 and 30 degrees Celsius.
White to pale yellow, rectangular, film-coated extended release three-layer tablets
30 tablets (6 tablets/PTP x 5)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 188.5mg
Tablet · Prescription medication
Dae Won Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.